EDGAR Filing Documents for 0001193125-16-802728

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-16-802728

Filing Date

2016-12-23

Accepted

2016-12-23 07:49:36

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d316585ds3.htm	S-3	197701
2	EX-5.1	d316585dex51.htm	EX-5.1	26682
3	EX-23.1	d316585dex231.htm	EX-23.1	2868
4	GRAPHIC	g316585g26s47.jpg	GRAPHIC	9971
5	GRAPHIC	g316585g34b46.jpg	GRAPHIC	3572
6	GRAPHIC	g316585g59k25.jpg	GRAPHIC	67159
7	GRAPHIC	g316585g70a41.jpg	GRAPHIC	5738
8	GRAPHIC	g316585g75n45.jpg	GRAPHIC	4362
9	GRAPHIC	g316585g76l05.jpg	GRAPHIC	14590
	Complete submission text file	0001193125-16-802728.txt		374122

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-215290 | Film No.: 162067925
SIC: 2834 Pharmaceutical Preparations